MALIA KEEN: Open Payments
NPI 1780294298 · VERO BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,372 in 194 payments from 46 companies in 2025. Trend: 2023 $4,246 · 2024 $4,740 · 2025 $4,372
Food & beverage: $4,257Education: $115
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 21 | $441 |
| AstraZeneca Pharmaceuticals LP | 12 | $392 |
| Merck Sharp & Dohme LLC | 15 | $354 |
| ABBVIE INC. | 14 | $305 |
| PFIZER INC. | 22 | $270 |
| Bayer Healthcare Pharmaceuticals Inc. | 14 | $196 |
| GlaxoSmithKline, LLC. | 8 | $175 |
| Novartis Pharmaceuticals Corporation | 7 | $160 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $148 |
| Ipsen Biopharmaceuticals, Inc | 5 | $135 |
Products named: KEYTRUDA, Nubeqa, TECVAYLI, VENCLEXTA, RYBREVANT, Onivyde, Orserdu, Xtandi.
Industry payments across FL — which companies pay providers there.
